Hengstschläger, Markus

In vitro cell migration and invasion assays

Kramer, N., Walzl, A., Unger, C., Rosner, M., Krupitza, G., Hengstschläger, M., & Dolznig, H. (2013) · Mutation Research/Reviews in Mutation Research

Cancer Cells and MetastasisCellular Mechanics and Interactions

Cited by 1,170

The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response

Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity

Immune Response and InflammationPI3K/AKT/mTOR signaling in cancer

Cited by 801

Comparison of cancer cells cultured in 2D vs 3D reveals differences in AKT/mTOR/S6-kinase signaling and drug response

Riedl, A., Schlederer, M., Pudelko, K., Stadler, M., Walter, S., Unterleuthner, D., Unger, C., Kramer, N., Hengstschläger, M., Kenner, L., et al. (2016) · Journal of Cell Science

PI3K/AKT/mTOR signaling in cancerCancer Cells and Metastasis

Cited by 389

Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression

Linke, M., Pham, H. T. T., Katholnig, K., Schnöller, T., Miller, A., Demel, F., Schütz, B., Rosner, M., Kovacic, B., Sukhbaatar, N., et al. (2017) · Nature Immunology

Sarcoidosis and Beryllium Toxicity ResearchTuberous Sclerosis Complex Research

Cited by 286

Modeling human carcinomas: Physiologically relevant 3D models to improve anti-cancer drug development

Unger, C., Kramer, N., Walzl, A., Scherzer, M., Hengstschläger, M., & Dolznig, H. (2014) · Advanced Drug Delivery Reviews

3D Printing in Biomedical ResearchCancer Cells and Metastasis

Cited by 158

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells

Weichhart, T., Haidinger, M., Katholnig, K., Kopecky, C., Poglitsch, M., Lassnig, C., Rosner, M., Zlabinger, G. J., Hengstschläger, M., Müller, M., et al. (2011) · Blood

PI3K/AKT/mTOR signaling in cancerImmune Response and Inflammation

Cited by 141

The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis

Appel, M., Forsthuber, M., Ramos, R., Widhalm, R., Granitzer, S., Uhl, M., Hengstschläger, M., Stamm, T., & Gundacker, C. (2022) · Journal of Toxicology and Environmental Health, Part B

Per- and polyfluoroalkyl substances researchToxic Organic Pollutants Impact

Cited by 104

Inverse data-driven modeling and multiomics analysis reveals Phgdh as a metabolic checkpoint of macrophage polarization and proliferation

Wilson, J. L., Nägele, T., Linke, M., Demel, F., Fritsch, S. D., Mayr, H. K., Cai, Z., Katholnig, K., Sun, X., Fragner, L., et al. (2020) · Cell Reports

Immune cells in cancerPI3K/AKT/mTOR signaling in cancer

Cited by 97

An mTORC1‐Dependent Mouse Model for Cardiac Sarcoidosis

Bueno‐Beti, C., Lim, C. X., Protonotarios, A., Szabo, P. L., Westaby, J., Mazic, M., Sheppard, M. N., Behr, E., Hamza, O., Kiss, A., et al. (2023) · Journal of the American Heart Association

Sarcoidosis and Beryllium Toxicity ResearchTuberous Sclerosis Complex Research

Cited by 34

Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems

Kiss, I., Neuwert, N., Oberle, R., Hengstschläger, M., Osmanagic-Myers, S., & Stangl, H. (2025) · Biomolecules

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 11